Free Trial
OTCMKTS:EXDI

Exactus (EXDI) Stock Price, News & Analysis

Exactus logo

About Exactus Stock (OTCMKTS:EXDI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
257,300 shs
Average Volume
83,144 shs
Market Capitalization
$38.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EXDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.

EXDI Stock News Headlines

Ish Msci France Regulatory News
“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Starbreeze AB B (STZEb)
Exactus, Inc. to Present at BIO CEO & Investor Conference
See More Headlines

EXDI Stock Analysis - Frequently Asked Questions

Exactus's stock reverse split on the morning of Thursday, October 28th 2021.The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactus investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and Aytu BioPharma (AYTU).

Company Calendar

Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EXDI
CIK
1552189
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.46 million
Net Margins
N/A
Pretax Margin
-15,131.74%
Return on Equity
-3,272.69%
Return on Assets
-185.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.32
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$2.07 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
599,005,000
Free Float
209,652,000
Market Cap
$38.94 million
Optionable
Not Optionable
Beta
4.21
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:EXDI) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners